Brain Cancer

About

General Information | Treatment Options | Additional Resources

Georgetown Brain Tumor Program

The Brain Tumor Program at the Lombardi Comprehensive Cancer Center provides comprehensive care to patients with a wide variety of primary benign and malignant tumors of the brain and spine including high grade gliomas (glioblastoma, anaplastic astrocytoma, gliosarcoma), oligodendrogliomas, ependymomas, meningiomas, and germinomas, to list only a few. The evaluation and management of brain tumors is complex, requiring a comprehensive approach with the involvement of experts from multiple specialties. Our care team consists of highly skilled neurosurgeons, medical and radiation oncologists, neuro-radiologists, neurologists, pathologists, social workers, case managers, palliative care practitioners, and clinical nurse coordinators. The team approach allows for the development of a well-coordinated plan of care, incorporating as needed either surgery (using intra-operative BrainLAB brain-mapping systems), radiation (external beam or stereotactic radiation including CyberKnife robotic radiosurgery), or systemic therapies (chemotherapy or biotherapies). The entire team of experts meets at a neuro-oncology tumor board on a bi-weekly basis to discuss all new cases, and obtain input from the whole team.

High-grade malignant gliomas are aggressive cancers, with median survival ranging from 12-15 months with current therapies. It is imperative that we explore novel therapies for patients with brain tumors to overcome resistance to chemotherapy and radiation. In addition to performing studies to understand the biology of these tumors, we are working to develop clinical trials for patients with brain tumors. Our team is dedicated in its fight against brain tumors, and believes in combining expert opinion with state-of-the art technology to provide compassionate and holistic care to our patients.

Deepa Subramaniam, MD, MS
Director, Brain Tumor Center

To make an appointment with a neuro-oncologist, please call 202-444-2223.

Learn more about:

Cancer information from the NCI PDQ service